CH681779A5 - - Google Patents

Download PDF

Info

Publication number
CH681779A5
CH681779A5 CH2658/90A CH265890A CH681779A5 CH 681779 A5 CH681779 A5 CH 681779A5 CH 2658/90 A CH2658/90 A CH 2658/90A CH 265890 A CH265890 A CH 265890A CH 681779 A5 CH681779 A5 CH 681779A5
Authority
CH
Switzerland
Prior art keywords
sep
inhibitor
phenyl
cells
aryl compound
Prior art date
Application number
CH2658/90A
Other languages
German (de)
English (en)
Inventor
Blaik Phillip Halling
Debra Ann Witkowski
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of CH681779A5 publication Critical patent/CH681779A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CH2658/90A 1988-12-12 1989-12-08 CH681779A5 (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28515188A 1988-12-12 1988-12-12
US33500789A 1989-04-07 1989-04-07
US35133189A 1989-05-03 1989-05-03

Publications (1)

Publication Number Publication Date
CH681779A5 true CH681779A5 (enExample) 1993-05-28

Family

ID=27403508

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2658/90A CH681779A5 (enExample) 1988-12-12 1989-12-08

Country Status (28)

Country Link
EP (1) EP0447491B1 (enExample)
JP (1) JP2545000B2 (enExample)
KR (1) KR930003116B1 (enExample)
AR (1) AR243605A1 (enExample)
AT (1) AT400520B (enExample)
AU (1) AU633537B2 (enExample)
BR (1) BR8907817A (enExample)
CA (1) CA2004979A1 (enExample)
CH (1) CH681779A5 (enExample)
DE (2) DE3991484T (enExample)
DK (1) DK110791A (enExample)
EG (1) EG18822A (enExample)
ES (1) ES2051675T3 (enExample)
FI (1) FI912784A7 (enExample)
GB (1) GB2247404B (enExample)
GR (1) GR1000609B (enExample)
HU (1) HUT58202A (enExample)
IE (1) IE62621B1 (enExample)
IL (1) IL92622A (enExample)
LU (1) LU87949A1 (enExample)
LV (1) LV10303B (enExample)
MC (1) MC2171A1 (enExample)
NO (1) NO912228L (enExample)
NZ (1) NZ231658A (enExample)
OA (1) OA09362A (enExample)
PT (1) PT92546B (enExample)
SE (1) SE505938C2 (enExample)
WO (1) WO1990006748A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298502A (en) * 1988-12-12 1994-03-29 Fmc Corporation Method and composition for photodynamic treatment and detection of tumors
US5132101A (en) * 1990-05-04 1992-07-21 Cytopharm, Inc. Acetylene-cumulene porphycene compounds for photodynamic therapy
US5244671A (en) * 1991-01-29 1993-09-14 Cytopharm, Inc. Derivatives of porphycene for photodynamic therapy of cancer
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
TW492975B (en) * 1993-07-26 2002-07-01 Novartis Ag Tryptase inhibitor
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
US5939602A (en) * 1995-06-06 1999-08-17 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
US6023012A (en) * 1996-02-28 2000-02-08 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase
US5767373A (en) 1994-06-16 1998-06-16 Novartis Finance Corporation Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US6084155A (en) * 1995-06-06 2000-07-04 Novartis Ag Herbicide-tolerant protoporphyrinogen oxidase ("protox") genes
CZ297325B6 (cs) * 1996-02-28 2006-11-15 Syngenta Participations Ag Molekula DNA kódující modifikovanou rostlinnou protoporfyrinogenoxidázu rezistentní k inhibitoru
JPH10330359A (ja) * 1997-03-31 1998-12-15 Nippon Bayeragrochem Kk フエニルアセチレン誘導体及び除草剤
DE102005017152B4 (de) * 2005-04-13 2007-02-08 Lindauer Dornier Gmbh Verfahren zum Trocknen von vorzugsweise plattenförmigen Produkten und Durchlauftrockner in Mehretagenbauweise
US8754008B2 (en) 2009-06-19 2014-06-17 Basf Se Herbicidal benzoxazinones
CN102686583A (zh) * 2009-11-02 2012-09-19 巴斯夫欧洲公司 除草的四氢邻苯二甲酰亚胺类
EP2621924B1 (en) * 2010-10-01 2015-03-04 Basf Se Herbicidal benzoxazinones
EP2651226B1 (en) 2010-12-15 2016-11-23 Basf Se Herbicidal compositions
CN102875569A (zh) * 2012-09-27 2013-01-16 南开大学 具有除草活性和抗肝癌活性的异噁唑并嘧啶酮(或三嗪酮)类化合物
US11185075B2 (en) * 2016-12-16 2021-11-30 Basf Se Herbicidal phenyltriazolinones

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393071A (en) * 1975-03-17 1983-07-12 Naoharu Fujii Method of treating gastric, mammary, lung and uterus tumors
US4404019A (en) * 1980-12-24 1983-09-13 Sumitomo Chemical Company, Limited 3-Chloro-1-phenyl-1,2,4-triazolin-5-ones and their use as herbicides
CH651029A5 (de) * 1980-12-25 1985-08-30 Nihon Nohyaku Co Ltd Triazolin-derivate, verfahren zu ihrer herstellung und sie enthaltende herbizide mittel.
JPS60190711A (ja) * 1984-03-09 1985-09-28 Tokyo Tanabe Co Ltd プロトポルフイリン類注射用製剤
US4761174A (en) * 1987-04-14 1988-08-02 Fmc Corporation Triazolin-5-one herbicides
US4755217A (en) * 1987-01-15 1988-07-05 Fmc Corporation Triazinedione herbicides

Also Published As

Publication number Publication date
FI912784A0 (fi) 1991-06-10
PT92546B (pt) 1995-09-12
HUT58202A (en) 1992-02-28
NZ231658A (en) 1992-05-26
OA09362A (en) 1992-09-15
GB2247404A (en) 1992-03-04
IE62621B1 (en) 1995-02-22
IE893925L (en) 1990-06-12
WO1990006748A3 (en) 1990-10-04
DE3991484T (enExample) 1991-11-21
IL92622A (en) 1996-05-14
JPH04501420A (ja) 1992-03-12
LU87949A1 (fr) 1991-12-16
IL92622A0 (en) 1990-08-31
BR8907817A (pt) 1991-10-22
KR910700046A (ko) 1991-03-13
ES2051675T1 (es) 1994-07-01
NO912228D0 (no) 1991-06-11
EP0447491B1 (en) 1993-08-11
WO1990006748A2 (en) 1990-06-28
KR930003116B1 (ko) 1993-04-19
AU633537B2 (en) 1993-02-04
GB9110472D0 (en) 1991-11-27
EG18822A (en) 1994-09-29
ES2051675T3 (es) 1994-11-01
PT92546A (pt) 1990-06-29
AT400520B (de) 1996-01-25
FI912784A7 (fi) 1991-06-10
LV10303B (en) 1995-08-20
DK110791A (da) 1991-08-12
CA2004979A1 (en) 1990-06-12
SE9101807L (sv) 1991-06-12
AR243605A1 (es) 1993-08-31
GB2247404B (en) 1993-03-03
DK110791D0 (da) 1991-06-11
JP2545000B2 (ja) 1996-10-16
SE505938C2 (sv) 1997-10-27
AU4822290A (en) 1990-07-10
ATA903489A (de) 1995-06-15
DE3991484C2 (de) 1995-02-23
GR890100817A (en) 1991-03-15
LV10303A (lv) 1994-10-20
SE9101807D0 (sv) 1991-06-12
NO912228L (no) 1991-06-11
MC2171A1 (fr) 1992-05-22
GR1000609B (el) 1992-08-31
EP0447491A1 (en) 1991-09-25

Similar Documents

Publication Publication Date Title
AT400520B (de) Protoporphyrinogeninhibitoren und deren verwendung in zusammensetzungen zur erkennung und behandlung von tumoren
US5407808A (en) Method and composition for photodynamic treatment and detection of tumors
US5298502A (en) Method and composition for photodynamic treatment and detection of tumors
DE69932733T2 (de) Photosensitizer-konjugate zur zielrichtung von intrazellulare pathogene
THImann et al. Phototropism and phototaxis
DE69928655T2 (de) Substituierte porphyrine
Giese Photosensitization by natural pigments
DE19825746A1 (de) Kombination von Selen-haltigen Verbindungen mit Zytostatika
EP0214839A2 (en) Improvements in relation to drug treatments
JPH02138201A (ja) ポリフィリン系殺虫剤
IE911971A1 (en) Treatment of disease
Giese Photosensitization of organisms, with special reference to natural photosensitizers
RU2074719C1 (ru) Способ разрушения опухолевых клеток млекопитающих и фармацевтическая композиция для разрушения опухолевых клеток млекопитающих
DD298882A5 (de) Einen spezifischen inhibitor enthaltendes arzneimittel und dessen verwendung in der tumorbehandlung
Verma et al. Curcumin ameliorates aflatoxin-induced changes in SDH and ATPase activities in liver and kidney of mice
HRP930762A2 (en) Preparation and use of porphyrin
Srivastava et al. Hypoglycemic effect of polyherbal formulations in alloxan induced diabetic mice
D'Ambrosio et al. marine drugs MDPI
Aigbiremolen et al. Renal morpho-functional changes in wistar rats. Administered Citrullus lanatus (Watermelon)
EP2863907A1 (de) Pharmazeutische zusammensetzung mit synergistischer wirkung von direkten katalaseinhibitoren und zur katalasezerstörung führenden modulatoren des no-stoffwechsels oder der extrazellulären superoxidanionenproduktion
DE202022104840U1 (de) Ein Protein in Nanoformulierung mit kardio-protektiver Wirkung
Giese Photosensitization of cells
Deng Investigations into the mechanism of action and antifungal activity of the botanical coumarin surangin B.
Gupta Gupta's MCQ & Review Series 10 in Toxicology-Toxic Effects of Plants
Glenn A HEPATOGENOUS PHOTOSENSITIVITY DISEASE OF CATTLE: LESIONS, FUNCTIONAL DISTURBANCES AND BIOCHEMICAL ALTERATIONS.